Loading...
•
Dec 31, 2021
Akoya Q4 2021 Earnings Report
Akoya reported a record quarterly revenue and grew its installed base.
Key Takeaways
Akoya Biosciences reported a strong finish to 2021 with record quarterly revenue of $16.2 million, representing a 26% increase compared to the prior year period. The company's installed base grew to nearly 700 instruments worldwide, and there are approximately 500 publications on Akoya platforms to date. The commercial launch of the PhenoCycler™-Fusion System was a highlight of the quarter.
Total revenue was $16.2 million, a 26% increase compared to the prior year period.
Product revenue was $12.9 million, a 23% increase compared to the prior year period.
Services and other revenue totaled $3.2 million, a 33% increase compared to the prior year period.
Gross profit was $10.2 million, a 29% increase compared to the prior year period, with a gross profit margin of 63.3%.
Akoya
Akoya
Akoya Revenue by Segment
Revenue by Segment
Product Revenue
CapyFin.comService and other Revenue
CapyFin.comRevenue & Expenses
Visualization of income flow from segment revenue to net income